Ownership history in STEMPOINT CAPITAL LP · 7 quarters on record
This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in DENALI THERAPEUTICS INC (DNLI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 419,058 | -1,315,601 | -75.8% | 1.19% | $6.9M | $16.51 |
| 2025 Q3 | ADDED | 1,734,659 | +1,026,744 | +145.0% | 5.05% | $25.2M | $14.52 |
| 2025 Q2 | ADDED | 707,915 | +40,837 | +6.1% | 3.18% | $9.9M | $13.99 |
| 2025 Q1 | ADDED | 667,078 | +82,750 | +14.2% | 2.89% | $9.1M | $13.60 |
| 2024 Q4 | ADDED | 584,328 | +302,278 | +107.2% | 2.97% | $11.9M | $20.38 |
| 2024 Q3 | ADDED | 282,050 | +31,040 | +12.4% | 2.46% | $8.2M | $29.13 |
| 2024 Q2 | INITIATED | 251,010 | — | — | 1.71% | $5.8M | — |
As of 2025 Q4 — sorted by position size